Bortezomib-Induced Pulmonary Toxicity: A Case Report and Review of Literature

Table 2

Outcome based on individual categorical variables: sex, new/relapsed/refractory type, prior SCT, smoking, previous lung injury, steroid just prior to BTZ, and concurrent chemotherapy ().

Variable		Outcome		value
		Death (%)	Resolution of BLI (%)
Sex	Female	6 (50)	6 (50)	0.2555
	Male	7 (30)	16 (70)
Type of BLI	New	3 (33)	6 (67)	0.8450
	Relapsed	7 (37)	12 (63)
	Refractory	2 (50)	2 (50)
Prior SCT	No	2 (11)	16 (89)	0.0360
	Yes	5 (45)	6 (55)
Smoking	No	6 (35)	11 (65)	0.1193
	Yes	0 (0)	5 (100)
Previous lung injuries	No	10 (50)	10 (50)	0.4726
	Yes	2 (33)	4 (67)
Prior or concurrent steroids	No	10 (34)	19 (66)	0.8116
	Yes	2 (40)	3 (60)
Concurrent chemotherapy	No	12 (41)	17 (59)	0.3636
	Yes	1 (20)	4 (80)

Chi-square test.